eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2022
vol. 47
 
Share:
Share:
Clinical immunology

β2-microglobulin alters the profiles of inflammatory cytokines and of matrix metalloprotease in macrophages derived from the osteoarthritic synovium

Kyoko Muneshige
1
,
Kentaro Uchida
1, 2
,
Jun Aikawa
1
,
Dai Iwase
1
,
Shotaro Takano
1
,
Masayuki Miyagi
1
,
Gen Inoue
1
,
Masashi Takaso
1

  1. Department of Orthopaedic Surgery, Kitasato University School of Medicine, Sagamihara City, Kanagawa, Japan
  2. Shonan University of Medical Sciences Research Institute, Chigasaki City, Kanagawa, Japan
Cent Eur J Immunol 2022; 47 (4): 332-338
Online publish date: 2023/01/13
Article file
- B2-microglobulin.pdf  [0.16 MB]
Get citation
 
PlumX metrics:
 

Introduction

Osteoarthritis (OA), the most prevalent form of joint disease, causes disability in adults by inducing pain and impaired joint function. Osteoarthritis is characterized by pain, stiffness, locomotor restriction, bony enlargement, and sometimes swelling of specific joints such as those in the knees, hips, hands and spine, which contribute to impaired function [1-3]. The exact mechanisms involved in the pathogenesis of OA are not fully understood.

Synovial tissues mainly consist of synovial fibroblasts and macrophages, both of which play a pivotal role in synovial inflammation [4-8]. Macrophages, in particular, are central to synovial inflammation through their production of inflammatory cytokines [7, 9-13]. Macrophages also produce various matrix metalloproteases (MMPs) [11, 14-16]. Investigating the factors that regulate synovial macrophage activation could be important for the development of OA treatments.

β2-microglobulin (B2M) is a component of class I major histocompatibility complex (MHC) located on the surface of nucleated cells [17-21]. Evidence suggests that B2M fibrils found in synovial tissue may contribute to osteoarticular complications in patients undergoing chronic hemodialysis (HD) with dialysis-related arthritis (DRA). Given that OA patients have high B2M concentrations in their synovial fluid [22], B2M may also stimulate MMP-1 expression in synovial fibroblasts in vitro [23]. Several studies have reported that B2M stimulates inflammatory cytokine production in the human embryonic kidney epithelial cell line HEK293 and murine monocyte cell lines in vitro [24]. However, the effect of B2M on MMP and inflammatory cytokine production in human primary synovial macrophages remains unclear.

Here, we investigated the effect of B2M on the expression profiles of inflammatory cytokines and MMPs in human synovial macrophages derived from the osteoarthritic synovium.

Material and methods

Patients

Six women with an age range of 60-78 years [mean ± standard deviation (SD), 68.3 ±5.8 years] with radiographic knee OA (Kellgren/Lawrence grade: KL3 = 5/6, KL4 = 1/6) who received total knee arthroplasty (TKA) at Kitasato University Hospital were enrolled in the study. During surgery, synovial tissue was extracted from the participants’ operated knee. All six women provided informed consent the day prior to surgery. The study protocol was approved by the Ethics Review Board of Kitasato University (reference number: KMEO B13–113).

Extraction of synovial CD14-positive cells

Patients’ synovial tissues were treated with 20 ml of 0.1% type I collagenase from Clostridium histoluticum (Wako Pure Chemicals, Osaka, Japan) for one day at 37°C. Isolated mononuclear cells were then incubated with 0.5 ml of biotin-conjugated anti-CD14 human monoclonal antibody (BioLegend) for 30 min at 4°C, before washing twice in phosphate-buffered saline (PBS). The cells were subsequently exposed to streptavidin-conjugated magnetic beads (BD Biosciences) and moved to a cell separation system (IMag; BD Biosciences) where they were left to stand at 4°C. Following a period of 30 min, the cells were removed from the magnetic support. To extract CD14+ cells, 5 ml of prewarmed (37°C) α-minimum essential medium (MEM) was added before centrifuging the cells at 280 g for 5 min. After trypan blue staining, CD14+ cells (1 × 105 cells/5 ml) were seeded in a 6-well culture plate.

Synovial cell culture

Synovial macrophages were maintained in culture for one week in medium containing 100 ng/ml macrophage colony-stimulating factor. A previous study reported that bovine B2M is present in bovine serum and is able to replace endogenous B2M associated with several class I antigens from human and mouse cells maintained in culture [17]. To reduce the effect of fetal bovine serum (FBS)-derived bovine B2M, cells were subsequently incubated in α-MEM containing 1% FBS and 1% penicillin/streptomycin for 3 h before culturing for 6 and 24 h in the presence of 10 µg/ml recombinant human B2M derived from Escherichia coli (Oriental Yeast Co., Tokyo, Japan). We confirmed that cell viability was not affected in this condition using the WST-8 assay. A previous study reported that the B2M concentration was 2.32 ±0.72 µg/ml in the synovial fluid of severe OA patients [22]. However, in in vitro conditions, 1 µg/ml B2M had no effect, while 10 µg/ml B2M inhibited chondrocyte growth and enhanced the effect of MMP-1 on synovial fibroblasts [22, 23]. Therefore, we used 10 µg/ml B2M to stimulate macrophages in this study. The remaining cells were used as controls. To determine the time points, we evaluated the gene expression of macrophage markers, inflammatory cytokines, and MMPs at 1, 3, 6, and 24 hours after B2M stimulation in a few samples. Because we observed increased gene expression at 6 and 24 hours, we cultured synovial macrophages for 6 and 24 h in α-MEM supplemented with 1% FBS and 1% penicillin/streptomycin only in this study.

Real-time PCR

Synovial macrophages were homogenized with TRI-zol Reagent with a homogenizer. After centrifugation, the supernatant was obtained and total RNA was extracted using Direct-zol RNA Micro Prep (Zymo Research, Irvine, CA) based on the manufacturer’s protocol. The SuperScript III First-Strand Synthesis Super Mix kit (Life Technologies, Thermo Fisher, Waltham, MA) was then used to conducted cDNA synthesis with the purified total RNA as the template. Table 1 lists the primer sequences adopted in this study. To examine macrophage marker (CD80, CD163 and CD206), inflammatory cytokine (IL-6, IL-8 and TNFA)] and matrix metalloproteinase (MMP-9 and MMP-13) mRNA expression, real-time PCR analysis (MiniOpticon, Bio-Rad, USA) was conducted on a PCR Master Mix (Takara SYBR PreMix Ex Taq II). Expression was normalized to GAPDH mRNA according to the delta-delta CT method.

Table 1

Sequences of primers used in this study

GeneDirectionPrimer sequence (5'–3')Product size (bp)
CD80FGCAGGGAACATCACCATCCA98
RTCACGTGGATAACACCTGAAC
CD163FGCTGGGACAGTTACGATGCT152
RTTGCCAGACAGCAGGTTCAT
CD206FGGGACGTGGCTGTGGATAAA115
RTCCAAAACCCAGAAGACGCA
IL-6FGAGGAGACTTGCCTGGTGAAA199
RTGGCATTTGTGGTTGGGTCA
IL-8FACACTGCGCCAACACAGAAA89
RCAACCCTCTGCACCCAGTTT
TNFAFCTTCTGCCTGCTGCACTTTG118
RGTCACTCGGGGTTCGAGAAG
MMP-9FTTTGAGTCCGGTGGACGATG197
RGCTCCTCAAAGACCGAGTCC
MMP-13FTGACTGAGAGGCTCCGAGAA111
RCATCAGGAACCCCGCATCTT
GAPDHFTGTTGCCATCAATGACCCCTT202
RCTCCACGACGTACTCAGCG

ELISA

To analyze the effect of B2M on IL-6, IL-8, TNF-α and MMP-13 production, we conducted enzyme-linked immunosorbent assay (ELISA) on the culture supernatant using a commercially available kit (LEGEND MAX Human ELISA Kit, BioLegend, San Diego, CA, USA) based on the manufacturer’s protocol.

Statistical analysis

Statistically significant differences between variables were determined using a paired t test or the Wilcoxon signed-rank test. Whether or not the data were normally distributed was ascertained using Shapiro-Wilk’s test. Variables that were found not to be normally distributed were analyzed using the Wilcoxon signed-rank test between vehicle and B2M groups at each time point. Statistical significance was indicated by p < 0.05. All analyses were performed with SPSS software v19.0 (IBM, USA).

Results

Real-time PCR analysis

Stimulation of synovial macrophages with B2M for 6 h caused mRNA expression of CD80 to significantly rise compared to that observed in vehicle control cells (p = 0.005, Fig. 1A). On the other hand, stimulation with 10 ng/ml B2M for 24 h caused CD163 mRNA expression to become significantly reduced relative to vehicle control cells (p = 0.028, Fig. 1B). Meanwhile, 24-h and 6-h stimulation had no effect on CD80 and CD163 mRNA expression, respectively (CD80, p = 0.917, CD163, p = 0.084; Fig. 1A, B). Likewise, 6-h (p = 0.225) and 24-h stimulation (p = 0.345) with B2M had no significant impact on CD206 mRNA expression (Fig. 1C).

Fig. 1

Macrophage marker, inflammatory cytokine and MMP mRNA levels in synovial macrophages following exposure to β2-microglobulin (B2M). mRNA expression of A) CD80, B) CD163, C) CD206, D) IL-6, E) IL-8, F) TNFA. *p < 0.05 G) MMP-9 and H) MMP-13 in synovial macrophages after stimulation with B2M for 6 and 24 h. *p < 0.05

/f/fulltexts/CEJOI/49898/CEJI-47-49898-g001_min.jpg

Stimulation of synovial macrophages with B2M for 6 h caused a significant increase in IL-6, IL-8 and TNFA mRNA levels compared to vehicle control cells (IL-6, p = 0.028, IL-8, p = 0.005, TNFA, p = 0.002; Fig. 1D-F). Similarly, stimulation for 24 h significantly elevated IL-6, IL-8 and TNFA mRNA expression relative to the vehicle control (IL-6, p = 0.028, IL-8, p = 0.028, TNFA, p = 0.046; Fig. 1D-F).

Stimulation with B2M for 6 h also significantly elevated MMP-13 mRNA expression compared to vehicle control cells (p = 0.004; Fig. 1H). In contrast, 24-h stimulation had no effect on MMP-13 mRNA expression (p = 0.917; Fig.1H). Similarly, MMP-9 mRNA expression did not change following 6-h or 24-h stimulation with B2M (p = 0.753, and p = 0.123, respectively; Fig. 1G).

ELISA

Stimulation of synovial macrophages with 10 ng/ml B2M for 6 h significantly elevated IL-6, IL-8 and TNF-α protein levels compared to vehicle control cells (IL-6, p = 0.013, IL-8, p = 0.028, TNF-α, p = 0.028; Fig. 2A-C). A similar increase was observed following 24 h of stimulation (IL-6, p = 0.007, IL-8, p = 0.028, TNF-α, p = 0.028; Fig. 2A-C). While MMP-13 protein levels were also significantly higher following 24-h stimulation with 10 ng/ml B2M (p = 0.028; Fig. 2D), no changes were observed after 6-h stimulation relative to vehicle control (p = 0.917; Fig. 2D).

Fig. 2

Amounts of IL-6, IL-8, TNF-α and MMP-13 generated by synovial macrophages following exposure to β2-microglobulin (B2M) determined using ELISA. Protein concentrations of A) IL6, B) IL8, C) TNF-α and D) MMP-13 produced by synovial macrophages after stimulation with B2M for 6 or 24 h. *p < 0.05

/f/fulltexts/CEJOI/49898/CEJI-47-49898-g002_min.jpg

Discussion

Macrophages respond to stimuli in their microenvironment by altering both their phenotype and function [25-27]. The synovium of OA patients harbors “M1” classically activated and “M2” alternatively activated macrophages, which are distinguished through their differentially expressed receptor and cytokine profiles [13, 25, 28, 29]. M1 macrophages predominantly express CD80 and produce inflammatory cytokines such as TNF-α, IL-6 and IL-8. In contrast, M2 macrophages preferentially express CD163 and CD206 [25, 30-32]. Further, the M1/M2 ratio has been shown to have a significant positive correlation with knee OA severity according to patients’ Kellgren-Lawrence grade [28]. Here, B2M promoted CD80 expression and increased TNF-α, IL-6, and IL-8 production, but decreased CD163 levels. A previous study reported B2M-mediated TNF-α production in the murine RAW 264.7 monocyte cell line [33]. Further, CD206+ M2-like macrophages have been shown to be increased in platelet-specific β2M knockout mice compared to wild type mice [34]. Taken together, our findings and those of previous reports suggest that B2M promotes synovial inflammation and contributes to OA pathology by promoting M1 polarization and inhibiting M2 polarization.

In addition to inflammatory cytokines, activated macrophages in the OA synovium secrete MMPs, which lead to cartilage degradation [9, 35-37]. Here, B2M increased MMP-13 mRNA expression at 6 h and MMP-13 protein production at 24 h in synovial macrophages. Therefore, stimulation with B2M temporarily increased mRNA expression, which led to subsequent protein synthesis. The lack of an earlier increase in MMP-13 protein may be due to the fact that protein synthesis takes time; hence, transcript changes may not have been reflected in protein levels at 6 h. Previous studies have indicated that macrophage polarization alters the MMP expression profile. MMP-9 and MMP-13 are dominantly expressed in M2 and M1 macrophages, respectively [11, 14-16]. Therefore, together with findings from other reports, our results suggest that increased MMP-13 may be associated with M1 polarization. Clinical reports have demonstrated increased MMP-13 levels in patients showing articular cartilage destruction, implicating high MMP-13 levels in cartilage degradation [38]. Further, a prior study demonstrated that transgenic mice with overexpression of Mmp-13 harbored several features of OA, including cartilage degradation [39]. B2M may thus contribute to cartilage destruction by increasing MMP-13.

A major strength of the present study was the use of primary human synovial macrophages derived from OA patients. However, there were also several limitations. First, synovial macrophages isolated from OA patients, even in the absence of stimulation with B2M, could exhibit basal pre-activation due to the presence of high levels of other damage-associated molecular patterns present in the inflamed joint. Further investigation using primary human macrophages (i.e. macrophages differentiated from the blood monocytes of healthy donors) is needed to confirm our findings. Second, we only studied the effects of a single dose of B2M. Finally, the mechanism by which B2M affects synovial macrophage polarization remains unclear.

In summary, B2M increased M1 macrophage marker, inflammatory cytokine, and MMP-13 expression in synovial macrophages. B2M-mediated activation of synovial macrophages may thus be associated with OA pathology.

Notes

[1] Conflicts of interest The authors declare no conflict of interest.

References

1 

Abhishek A, Doherty M (2013): Diagnosis and clinical presentation of osteoarthritis. Rheum Dis Clin North Am 39: 45-66.

2 

Chen Y, Jiang W, Yong H, et al. (2020): Macrophages in osteoarthritis: pathophysiology and therapeutics. Am J Transl Res 12: 261-268.

3 

Hugle T, Geurts J (2017): What drives osteoarthritis?-synovial versus subchondral bone pathology. Rheumatology (Oxford) 56: 1461-1471.

4 

Benito MJ, Veale DJ, FitzGerald O, et al. (2005): Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 64: 1263-1267.

5 

Bondeson J, Wainwright SD, Lauder S, et al. (2006): The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res Ther 8: R187.

6 

Farahat MN, Yanni G, Poston R, Panayi GS (1993) Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 52: 870-875.

7 

Goldenberg DL, Egan MS, Cohen AS (1982): Inflammatory synovitis in degenerative joint disease. J Rheumatol 9: 204-209.

8 

Knab K, Chambers D, Kronke G (2022): Synovial macrophage and fibroblast heterogeneity in joint homeostasis and inflammation. Front Med (Lausanne) 9: 862161.

9 

Blom AB, van Lent PL, Holthuysen AE, et al. (2004): Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 12: 627-635.

10 

Griffin TM, Scanzello CR (2019): Innate inflammation and synovial macrophages in osteoarthritis pathophysiology. Clin Exp Rheumatol 37 Suppl 120: 57-63.

11 

Hayes EM, Tsaousi A, Di Gregoli K, et al. (2014): Classical and alternative activation and metalloproteinase expression occurs in foam cell macrophages in male and female ApoE null mice in the absence of T and B lymphocytes. Front Immunol 5: 537.

12 

Mushenkova NV, Nikiforov NG, Shakhpazyan NK, et al. (2022): Phenotype diversity of macrophages in osteoarthritis: implications for development of macrophage modulating therapies. Int J Mol Sci 23: 8381.

13 

Zhang H, Cai D, Bai X (2020): Macrophages regulate the progression of osteoarthritis. Osteoarthritis Cartilage 28: 555-561.

14 

Jager NA, Wallis de Vries BM, Hillebrands JL, et al. (2016): Distribution of matrix metalloproteinases in human atherosclerotic carotid plaques and their production by smooth muscle cells and macrophage subsets. Mol Imaging Biol 18: 283-291.

15 

Tian K, Du G, Wang X, et al. (2022): MMP-9 secreted by M2-type macrophages promotes Wilms’ tumour metastasis through the PI3K/AKT pathway. Mol Biol Rep 2022; 49: 3469-3480.

16 

Lavin B, Gomez M, Pello OM, et al. (2014): Nitric oxide prevents aortic neointimal hyperplasia by controlling macrophage polarization. Arterioscler Thromb Vasc Biol 34: 1739-1746.

17 

Bernabeu C, van de Rijn M, Lerch PG, Terhorst CP (1984): Beta 2-microglobulin from serum associates with MHC class I antigens on the surface of cultured cells. Nature 308: 642-645.

18 

Gussow D, Rein R, Ginjaar I, et al. (1987): The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit. J Immunol 139: 3132-3138.

19 

Hochman JH, Shimizu Y, DeMars R, Edidin M (1988): Specific associations of fluorescent beta-2-microglobulin with cell surfaces. The affinity of different H-2 and HLA antigens for beta-2-microglobulin. J Immunol 140: 2322-2329.

20 

Revillard JP, Vincent C (1988): Structure and metabolism of beta-2-microglobulin. Contrib Nephrol 62: 44-53.

21 

Rosano C, Zuccotti S, Bolognesi M (2005): The three-dimensional structure of beta2 microglobulin: results from X-ray crystallography. Biochim Biophys Acta 1753: 85-91.

22 

Zhang H, Liew CC, Marshall KW (2002): Microarray analysis reveals the involvement of beta-2 microglobulin (B2M) in human osteoarthritis. Osteoarthritis Cartilage 10: 950-960.

23 

Moe SM, Singh GK, Bailey AM (2000): beta2-microglobulin induces MMP-1 but not TIMP-1 expression in human synovial fibroblasts. Kidney Int 57: 2023-2034.

24 

Kaneko N, Mori W, Kurata M, et al. (2022): Inflammasome assembly is required for intracellular formation of beta2-microglobulin amyloid fibrils, leading to IL-1beta secretion. Int J Immunopathol Pharmacol 36: 3946320221104554.

25 

Mosser DM, Edwards JP (2008): Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.

26 

Stout RD, Jiang C, Matta B, et al. (2005): Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 175: 342-349.

27 

McWhorter FY, Davis CT, Liu WF (2015): Physical and mechanical regulation of macrophage phenotype and function. Cell Mol Life Sci 72: 1303-1316.

28 

Liu B, Zhang M, Zhao J, et al. (2018): Imbalance of M1/M2 macrophages is linked to severity level of knee osteoarthritis. Exp Ther Med 16: 5009-5014.

29 

Zhang H, Lin C, Zeng C, et al. (2018): Synovial macrophage M1 polarisation exacerbates experimental osteoarthritis partially through R-spondin-2. Ann Rheum Dis 77: 1524-1534.

30 

Manferdini C, Paolella F, Gabusi E, et al. (2017): Adipose stromal cells mediated switching of the pro-inflammatory profile of M1-like macrophages is facilitated by PGE2: in vitro evaluation. Osteoarthritis Cartilage 25: 1161-1171.

31 

Lucas T, Waisman A, Ranjan R, et al. (2010): Differential roles of macrophages in diverse phases of skin repair. J Immunol 184: 3964-3977.

32 

Murray PJ, Allen JE, Biswas SK, et al. (2014): Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41: 14-20.

33 

Menaa C, Esser E, Sprague SM (2008): Beta2-microglobulin stimulates osteoclast formation. Kidney Int 73: 1275-1281.

34 

Hilt ZT, Ture SK, Mohan A, et al. (2019): Platelet-derived beta2m regulates age related monocyte/macrophage functions. Aging (Albany NY) 11: 11955-11974.

35 

Blom AB, van Lent PL, Libregts S, et al. (2007): Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis Rheum 56: 147-157.

36 

Scanzello CR, Plaas A, Crow MK (2008): Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound? Curr Opin Rheumatol 20: 565-572.

37 

Sokolove J, Lepus CM (2013): Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis 5: 77-94.

38 

Roach HI, Yamada N, Cheung KS, et al. (2005): Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum 52: 3110-3124.

39 

Wu Q, Kim KO, Sampson ER, et al. (2008): Induction of an osteoarthritis-like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice. Arthritis Rheum 58: 3132-3144.

Copyright: © 2023 Polish Society of Experimental and Clinical Immunology This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.